Literature DB >> 3040774

Mouse ovarian granulosa cells produce urokinase-type plasminogen activator, whereas the corresponding rat cells produce tissue-type plasminogen activator.

R Canipari, M L O'Connell, G Meyer, S Strickland.   

Abstract

It is well established that rat ovarian granulosa cells produce tissue plasminogen activator (tPA). The synthesis and secretion of the enzyme are induced by gonadotropins, and correlate well with the time of follicular rupture in vivo. We have found that in contrast, mouse granulosa cells produce a different form of plasminogen activator, the urokinase-type (uPA). As with tPA synthesis in the rat, uPA production by mouse granulosa cells is induced by gonadotropins, dibutyryl cAMP, and prostaglandin E2. However, dexamethasone, a drug which has no effect on tPA synthesis in rat cells inhibits uPA synthesis in the mouse. Results of these determinations made in cell culture were corroborated by examining follicular fluid, which is secreted in vivo predominantly by granulosa cells, from stimulated rat and mouse ovarian follicles. Rat follicular fluid contained only tPA, and mouse follicular fluid only uPA, indicating that in vivo, granulosa cells from the two species are secreting different enzymes. The difference in the type of plasminogen activator produced by the rat and mouse granulosa cells was confirmed at the messenger RNA level. After hormone stimulation, only tPA mRNA was present in rat cells, whereas only uPA mRNA was found in mouse cells. Furthermore, the regulation of uPA levels in mouse cells occurs via transient modulation of steady-state levels of mRNA, a pattern similar to that seen with tPA in rat cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040774      PMCID: PMC2114761          DOI: 10.1083/jcb.105.2.977

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  22 in total

1.  Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator.

Authors:  D Belin; J D Vassalli; C Combépine; F Godeau; Y Nagamine; E Reich; H P Kocher; R M Duvoisin
Journal:  Eur J Biochem       Date:  1985-04-15

Review 2.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

3.  Plasminogen activator in the rat ovary. Production and gonadotropin regulation of the enzyme in granulosa and thecal cells.

Authors:  R Canipari; S Strickland
Journal:  J Biol Chem       Date:  1985-04-25       Impact factor: 5.157

4.  Plasminogen activator in mouse and rat oocytes: induction during meiotic maturation.

Authors:  J Huarte; D Belin; J D Vassalli
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

5.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

6.  The production of distinct forms of plasminogen activator by mouse embryonic cells.

Authors:  K R Marotti; D Belin; S Strickland
Journal:  Dev Biol       Date:  1982-03       Impact factor: 3.582

7.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

8.  A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma.

Authors:  J H Verheijen; E Mullaart; G T Chang; C Kluft; G Wijngaards
Journal:  Thromb Haemost       Date:  1982-12-27       Impact factor: 5.249

9.  Cultured granulosa cells produce two plasminogen activators and an antiactivator, each regulated differently by gonadotropins.

Authors:  T Ny; L Bjersing; A J Hsueh; D J Loskutoff
Journal:  Endocrinology       Date:  1985-04       Impact factor: 4.736

10.  Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages.

Authors:  J D Vassalli; J M Dayer; A Wohlwend; D Belin
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

View more
  10 in total

1.  Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column.

Authors:  P Andrade-Gordon; S Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

2.  Engineering the ovarian cycle using in vitro follicle culture.

Authors:  Robin M Skory; Yuanming Xu; Lonnie D Shea; Teresa K Woodruff
Journal:  Hum Reprod       Date:  2015-03-16       Impact factor: 6.918

3.  Intracellular activation of ovastacin mediates pre-fertilization hardening of the zona pellucida.

Authors:  Hagen Körschgen; Michael Kuske; Konstantin Karmilin; Irene Yiallouros; Melanie Balbach; Julia Floehr; Dagmar Wachten; Willi Jahnen-Dechent; Walter Stöcker
Journal:  Mol Hum Reprod       Date:  2017-09-01       Impact factor: 4.025

Review 4.  Regulation of HGF and c-MET Interaction in Normal Ovary and Ovarian Cancer.

Authors:  Youngjoo Kwon; Andrew K Godwin
Journal:  Reprod Sci       Date:  2016-09-27       Impact factor: 3.060

5.  Immunohistochemical localization of tissue-type plasminogen activator in ovaries before and after induced and spontaneous ovulation in the rat.

Authors:  S B Cajander; M P Hugin; P Kristensen; A J Hsueh
Journal:  Cell Tissue Res       Date:  1989-07       Impact factor: 5.249

6.  In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis.

Authors:  E Bacharach; A Itin; E Keshet
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

7.  Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: functional redundancy among physiological plasminogen activators.

Authors:  G Leonardsson; X R Peng; K Liu; L Nordström; P Carmeliet; R Mulligan; D Collen; T Ny
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

8.  Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos.

Authors:  A P Sappino; J Huarte; D Belin; J D Vassalli
Journal:  J Cell Biol       Date:  1989-11       Impact factor: 10.539

9.  Mammalian plasma fetuin-B is a selective inhibitor of ovastacin and meprin metalloproteinases.

Authors:  Konstantin Karmilin; Carlo Schmitz; Michael Kuske; Hagen Körschgen; Mario Olf; Katharina Meyer; André Hildebrand; Matthias Felten; Sven Fridrich; Irene Yiallouros; Christoph Becker-Pauly; Ralf Weiskirchen; Willi Jahnen-Dechent; Julia Floehr; Walter Stöcker
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

10.  Human monocytes can produce tissue-type plasminogen activator.

Authors:  P H Hart; G F Vitti; D R Burgess; D K Singleton; J A Hamilton
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.